These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6734917)

  • 1. Effect of pindolol and nifedipine alone and in combination on haemodynamic parameters/variables in essential hypertension.
    Tsukiyama H; Otsuka K; Yamamoto Y
    J Int Med Res; 1984; 12(3):154-62. PubMed ID: 6734917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand; 1976; 199(4):251-5. PubMed ID: 1266662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand; 1977; 202(6):517-21. PubMed ID: 339674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic evaluation of pindolol].
    Biffani G; Santini M
    Minerva Cardioangiol; 1976 Sep; 24(9):613-8. PubMed ID: 1012501
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic study of nifedipine administration in hypertensive patients.
    Bonaduce D; Ferrara N; Petretta M; Romano E; Postiglione M; Rengo F; Condorelli M
    Am Heart J; 1983 May; 105(5):865-7. PubMed ID: 6846133
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic effect of sublingual nifedipine in patients with congestive heart failure.
    Wasir HS; Sood AK
    Indian Heart J; 1984; 36(1):8-14. PubMed ID: 6706374
    [No Abstract]   [Full Text] [Related]  

  • 7. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M; Heikkilä J
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
    Cocco G; Strozzi C; Chu D; Amrein R; Castagnoli E
    Eur J Cardiol; 1979 Jul; 10(1):59-69. PubMed ID: 111940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of pindolol in hypertensive patients.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand Suppl; 1977; 606():55-62. PubMed ID: 268933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
    Welzel D; Bräutigam M
    Arzneimittelforschung; 1989 Apr; 39(4):499-503. PubMed ID: 2568838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the treatment with propranolol and pindolol on selected hemodynamic parameters in patients with primary arterial hypertension].
    Trojnar R; Markiewicz M; Rymar B; Wysokiński A
    Wiad Lek; 1989 Aug 15-Sep 15; 42(16-18):929-34. PubMed ID: 2701039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
    Atterhög JH; Dunér H; Pernow B
    Am J Med; 1976 May; 60(6):872-6. PubMed ID: 14501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
    Nifedipine-Atenolol Study Review Committee
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of hemodynamic changes in patients with primary arterial hypertension after treatment with a combination of pindolol and clopamide (Viskaldix)].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1991; 34(5):286-91. PubMed ID: 1921111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of nifedipine in hypertension in the presence of elevated angiotensin-II and beta-adrenergic blockade.
    Blau A; Battler A; Eldar M; Rath S; Neufeld HN; Kapuler S; Iaina A; Cohen D; Eliahou HE
    J Clin Hypertens; 1986 Mar; 2(1):13-20. PubMed ID: 2873210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stress hemodynamics in hypertensive patients treated with nifedipine].
    Zott HJ; Kästner C; Bansi D; Wallrabe D
    Z Gesamte Inn Med; 1989 Dec; 44(23):711-4. PubMed ID: 2629367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation.
    Gretzer I; Dunér H; Lagerbäck B
    J Hypertens Suppl; 1985 Dec; 3(3):S215-7. PubMed ID: 2856707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension].
    Klein WW; Brandt D; Fluch N; Goebel R; Holzer H; Pöch G
    Adv Clin Pharmacol; 1976; 11():79-85. PubMed ID: 1032573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.